Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Anton Camaj(Columbia University Irving Medical Center), Gennaro Giustino(Cardiovascular Institute of the South), Michael S. Miller(Mount Sinai Hospital), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai)
Cited by 2
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
|Stroke|2006|1.9k
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
|Stroke|2010|1.5k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919